Actual product appearance and labeling of the medication you receive will differ from website images
Valyi-Nagy, T., Deschmane, S
Is It Safe to Take NAD+ and Glutathione Together
peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events
Appropriate research applications may include: molecular biology peptide chemistry receptor biology protein signalling research cell culture investigations experimental pharmacology biochemical analysis translational research Laboratory Handling Appropriate laboratory procedures support both researcher safety and experimental reproducibility
10.1016/S0024-3205(02)01911-2 Life Sci
